Kindly note the image has been posted only for representational purposes.Photograph: Kind courtesy Pixabay.com The Indian pharmaceutical industry's recent tryst with the US drug regulator......
Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering......
While Lupin is working on a Remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus......
Drugs that are used to treat Covid or used by people as immunity boosters have seen a jump in sales and, in turn, rankings, reports Sohini Das. IMAGE: A chemist displays the Fabiflu......
Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With more drugmakers in line to launch the drug soon, the prices may see a further erosion. Sohini Das reports. IMAGE: An......
The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......
In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country’s pharmaceuticals sector. Illustration:......
How Hiren Patel, founder Karsanbhai’s son, is reinvigorating Nirma by administering a shot of pharma. Illustration: Dominic Xavier/Rediff.com Nirma’s tryst with the pharmaceutical......
Detergent to chemicals major Nirma Ltd is planning to tap into its own funds and raise debt to fund its Rs 5,652 crore acquisition of Glenmark Life Sciences. The firm has roped in BCG and KPMG to......
Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,651.5 crore. Photograph: PTI Photo from the Rediff......